Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 23, 2007

Primary Completion Date

May 31, 2010

Study Completion Date

December 31, 2011

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL

bevacizumab

DRUG

fluorouracil

DRUG

irinotecan hydrochloride

DRUG

leucovorin calcium

GENETIC

polymorphism analysis

Trial Locations (1)

Institut Bergonie, Bordeaux